ANI Pharmaceuticals, Inc. (ANIP)
NASDAQ: ANIP · Real-Time Price · USD
72.00
-1.16 (-1.59%)
Oct 30, 2026, 4:00 PM EDT - Market closed
ANI Pharmaceuticals Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| J.P. Morgan | J.P. Morgan | Buy Maintains $115 | Buy | Maintains | $115 | +59.72% | Oct 22, 2026 |
| Guggenheim | Guggenheim | Buy Reiterates $119 | Buy | Reiterates | $119 | +65.28% | Oct 6, 2026 |
| Oppenheimer | Oppenheimer | Hold Initiates $85 | Hold | Initiates | $85 | +18.06% | Sep 23, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $121 | Buy | Maintains | $121 | +68.06% | Sep 21, 2026 |
| Leerink Partners | Leerink Partners | Buy Initiates $104 | Buy | Initiates | $104 | +44.44% | Sep 9, 2026 |
| Barclays | Barclays | Buy Maintains $100 | Buy | Maintains | $100 | +38.89% | Aug 26, 2026 |
Unknown Analyst Jefferies No rating | Jefferies | Buy Reiterates $120 | Buy | Reiterates | $120 | +66.67% | Aug 10, 2026 |
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $91 → $90 | Hold | Maintains | $91 → $90 | +25.00% | Aug 10, 2026 |